Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Djamilatou Adom

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Expert Review of Clinical Immunology|April 10, 2018
The search for drug-targetable diagnostic, prognostic and predictive biomarkers in chronic graft-versus-host diseaseHong-Gang Ren, Djamilatou Adom, Sophie Paczesny
Frontiers in Immunology|May 7, 2020
Biomarkers for Allogeneic HCT OutcomesDjamilatou Adom, Courtney Rowan, Titilayo Adeniyan, et al.
The Journal of Experimental Medicine|October 18, 2017
Specifically differentiated T cell subset promotes tumor immunity over fatal immunityAbdulraouf Ramadan, Brad Griesenauer, Djamilatou Adom, et al.
The Journal of Investigative Dermatology|April 4, 2022
γδ T Cell‒Mediated Wound Healing Is Diminished by Allergic Skin InflammationJocelyn Wang, Abigail Pajulas, Yongyao Fu, et al.
The Journal of Clinical Investigation|August 1, 2023
Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and deathBrent R Logan, Denggang Fu, Alan Howard, et al.
JCI Insight|August 19, 2020
Granzyme A-producing T helper cells are critical for acute graft-versus-host diseaseSungtae Park, Brad Griesenauer, Hua Jiang, et al.
Blood|October 17, 2021
Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learningShannon R McCurdy, Vedran Radojcic, Hua-Ling Tsai, et al.
Science Translational Medicine|October 8, 2020
ICOSL<sup>+</sup> plasmacytoid dendritic cells as inducer of graft-versus-host disease, responsive to a dual ICOS/CD28 antagonistDjamilatou Adom, Stacey R Dillon, Jinfeng Yang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Expert Review of Clinical Immunology|April 10, 2018
The search for drug-targetable diagnostic, prognostic and predictive biomarkers in chronic graft-versus-host diseaseHong-Gang Ren, Djamilatou Adom, Sophie Paczesny
Frontiers in Immunology|May 7, 2020
Biomarkers for Allogeneic HCT OutcomesDjamilatou Adom, Courtney Rowan, Titilayo Adeniyan, et al.
The Journal of Experimental Medicine|October 18, 2017
Specifically differentiated T cell subset promotes tumor immunity over fatal immunityAbdulraouf Ramadan, Brad Griesenauer, Djamilatou Adom, et al.
The Journal of Investigative Dermatology|April 4, 2022
γδ T Cell‒Mediated Wound Healing Is Diminished by Allergic Skin InflammationJocelyn Wang, Abigail Pajulas, Yongyao Fu, et al.
The Journal of Clinical Investigation|August 1, 2023
Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and deathBrent R Logan, Denggang Fu, Alan Howard, et al.
JCI Insight|August 19, 2020
Granzyme A-producing T helper cells are critical for acute graft-versus-host diseaseSungtae Park, Brad Griesenauer, Hua Jiang, et al.
Blood|October 17, 2021
Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learningShannon R McCurdy, Vedran Radojcic, Hua-Ling Tsai, et al.
Science Translational Medicine|October 8, 2020
ICOSL<sup>+</sup> plasmacytoid dendritic cells as inducer of graft-versus-host disease, responsive to a dual ICOS/CD28 antagonistDjamilatou Adom, Stacey R Dillon, Jinfeng Yang, et al.
Pageof 1